With reference to a news item published in a leading financial daily titled 'Ranbaxy dips two per cent on penalty reports', Ranbaxy Laboratories Ltd has informed BSE that neither the company nor its UK based subsidiary has received any notice for any civil action in regard to pricing of Penicillin-based drugs in UK.
BSE Code: 500359
© 2026